RestructuringJul 2, 2026, 05:03 PM
Tenaya Therapeutics Terminates Manufacturing Lease, Forfeits $1.75M
AI Summary
Tenaya Therapeutics, Inc. has entered into a Lease Termination Agreement for its 94,046 square foot Genetic Medicines Manufacturing Center in Union City, California. The facility was decommissioned in 2025 to reduce costs, and the lease, originally set to expire in July 2031, will now terminate on August 31, 2026. As consideration, the company will forfeit its $1,750,000 security deposit and pay a one-time lease termination fee of approximately $294,200. This move allows Tenaya to transfer its AAV manufacturing process to a contract development manufacturing organization.
Key Highlights
- Lease for 94,046 sq ft Genetic Medicines Manufacturing Center terminated.
- Lease termination effective August 31, 2026, instead of July 2031.
- Company to forfeit $1,750,000 security deposit.
- Company to pay a one-time lease termination fee of approximately $294,200.
- GMMC Facility decommissioned in 2025 to reduce costs.
- AAV manufacturing process to be transferred to a contract development manufacturing organization.
Price Impact
More from TNYA